ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

STA adds to drug service offerings

by Rick Mullin
April 3, 2017 | APPEARED IN VOLUME 95, ISSUE 14

STA Pharmaceuticals, a division of the Chinese pharmaceutical services firm WuXi AppTec, is building its first commercial-scale finished drug facility. The company, which has manufactured clinical-scale finished drugs near Shanghai since 2007, will expand to commercial scale there and add production at its site in the city of Wuxi. The company ­recently added a pilot plant in Changzhou in a project aimed at integrating research and pharmaceutical chemical production. STA plans to double the number of process chemistry labs in Changzhou to 48, adding hydrogenation and catalysis labs, by the end of this year.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment